Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults

Clinical trial NCT01993706 · COMPLETED

Trial details

NCT number: NCT01993706
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV Infection Monoclonal Antibody, Human HIV Antibodies VRC01 Monoclonal Antibody Neutralizing Antibody

Start date: 2013-11-19
Primary completion: 2015-02-27
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.